HighVista Strategies »

Applovin Corp Class A shares owned by HighVista Strategies

Quarter-by-quarter ownership of Applovin Corp Class A (APP) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Applovin Corp Class A

Tip: Access up to 7 years of quarterly data

All positions including Applovin Corp Class A held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Applovin Corp Class A by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 2.5k 673.82

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Structure Therapeutics Sponsored Ads (GPCR)
Cogent Biosciences (COGT)
Miragen Therapeutics (VRDN)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Praxis Precision Medicines I Com New (PRAX)
Nuvalent Inc-a (NUVL)
Cytokinetics Com New (CYTK)
Terns Pharmaceuticals (TERN)
Maze Therapeatics (MAZE)
Insmed Com Par $.01 (INSM)
Apogee Therapeutics (APGE)
Protagonist Therapeutics (PTGX)
Soleno Therapeutics (SLNO)

View all positions for HighVista Strategies

Top funds holding Applovin Corp Class A

Vanguard Group
BlackRock
Vanguard Capital Management
Ieq Capital
FMR
State Street Corporation
Susquehanna International
Geode Capital Management
Baillie Gifford & Co
Vanguard Portfolio Management
Jane Street
Morgan Stanley
Citadel Advisors
WCM Investment Management
Invesco

View all funds holding Applovin Corp Class A